By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site ...

Moderna's COVID-19 vaccine has received full approval from the U.S. Food and Drug Administration (FDA) for use in children ...

A study by AIIMS Delhi revealed that nearly 40% of long Covid sufferers experience persistent fatigue, and 25% report ...

DHAKA, July 11, 2025 (BSS) - The Directorate General of Health Services (DGHS) today confirmed three new Covid-19 infections ...

Bangladesh is finally experiencing some relief. The virus has slowed down, with no new deaths or hospitalizations reported in ...

The Food and Drug Administration Thursday granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...

The new variant has come out of seemingly nowhere, but now is fast becoming the dominant strain of the potentially deadly ...

Spread This NewsBy Anna Chibamu The government has dismissed reports of any Covid-19 variants currently circulating in ...

USAID shipped thousands of virus samples to the epicenter of the COVID-19 pandemic without biosecurity agreements and ...

The full approval of Spikevax covers children aged six months through 11 years who are at increased risk for severe COVID-19, transitioning the vaccine from emergency use to full licensure.

Vaccine maker Moderna announced today that the US Food and Drug Administration (FDA) has granted full approval of its ...